New and updated preclinical and clinical data presented by biopharma firms at the American College of Cardiology’s 69th Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC Virtual), including: Astrazeneca, Cytokinetics, Esperion, Janssen, Kiniksa, Merck, Mesoblast, Novartis, Regeneron.